8-KThe WireRoutine
Bylaw Amendment
Filed Jun 12, 2026 · 18d ago · Accession 0001493152-26-028457
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- GT Biopharma, Inc.
- Ticker
- GTBP
- CIK
- 109657
- Form type
- 8-K
- Filing date
- Jun 12, 2026
- Report date
- Jun 8, 2026
- Document
- form8-k.htm
- Size
- 216 KB